Identification of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Intracranial Aneurysm.

BACKGROUND Intracranial aneurysm (IA) is a cerebrovascular disorder characterized by an abnormally bulged artery in the brain and subarachnoid hemorrhage caused by IA rupture with a high ratio of fatality and morbidity. However, the genetic cause of IA remains largely unknown. METHODS A dysregulated long noncoding RNA (lncRNA) -associated competing endogenous RNA (ceRNA) network was constructed by using sample-matched microRNA (miRNA), lncRNA, and messenger (mRNA) expression profiles in 12 saccular IA samples and paired control arteries. RESULTS In this study, 1150 lncRNAs, 2545 mRNAs, and 286 miRNAs were differentially expressed in IAs compared with control arteries. Using miRanda, a ceRNA score was assigned, and gene expression methods were used to construct a ceRNA network. The network consists of 8401 miRNA-lncRNA-mRNA interactions (199 miRNAs, 445 lncRNAs, 1116 mRNAs; P < 0.05). Further Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis indicated that the mRNAs involved in the ceRNA network were involved in the regulation of muscle contraction and vascular smooth muscle contraction. CONCLUSIONS By comparing IAs and their control arteries, we identified differentially expressed lncRNAs, miRNAs, and mRNAs and suggested ceRNA roles in the pathogenesis of IA. These findings may help to characterize the pathogenesis of IA and provide novel therapeutic targets in the future for patients with IA.

[1]  P. Pandolfi,et al.  The multilayered complexity of ceRNA crosstalk and competition , 2014, Nature.

[2]  Ming Cui,et al.  microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[3]  B. Weir.  Unruptured intracranial aneurysms: a review. , 2002, Journal of neurosurgery.

[4]  G. Owens,et al.  Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. , 2012, Annual review of physiology.

[5]  Jiayi Wang,et al.  CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer , 2010, Nucleic acids research.

[6]  D. Ding,et al.  Vascular Smooth Muscle Cells in Cerebral Aneurysm Pathogenesis , 2013, Translational Stroke Research.

[7]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[8]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[9]  Yan Liu,et al.  Expression of NF-κB, MCP-1 and MMP-9 in a Cerebral Aneurysm Rabbit Model , 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[10]  Jesse D. Roberts,et al.  Aortic Aneurysm Generation in Mice With Targeted Deletion of Integrin-Linked Kinase in Vascular Smooth Muscle Cells , 2011, Circulation research.

[11]  Lanbing Yu,et al.  Gene expression profiles in intracranial aneurysms , 2014, Neuroscience Bulletin.

[12]  W. Koch,et al.  Biology of Intracranial Aneurysms: Role of Inflammation , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  M. Piechota,et al.  Gene Expression Profiles in Human Ruptured and Unruptured Intracranial Aneurysms: What Is the Role of Inflammation? , 2010, Stroke.

[14]  I. Inoue,et al.  Gene Expression Profiling Reveals Distinct Molecular Signatures Associated With the Rupture of Intracranial Aneurysm , 2014, Stroke.

[15]  S. Roman,et al.  Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia. , 2014, American journal of human genetics.

[16]  E. Connolly,et al.  The role of vascular remodeling and inflammation in the pathogenesis of intracranial aneurysms , 2014, Journal of Clinical Neuroscience.

[17]  M. Yılmaz,et al.  The Role of the CCR2 Gene Polymorphism in Abdominal Aortic Aneurysms , 2011, Angiology.

[18]  Lijuan Qian,et al.  miRNA-dependent cross-talk between VEGF and Ang-2 in hypoxia-induced microvascular dysfunction. , 2014, Biochemical and biophysical research communications.

[19]  Shaoli Das,et al.  lnCeDB: Database of Human Long Noncoding RNA Acting as Competing Endogenous RNA , 2014, PloS one.

[20]  G. Sukhova,et al.  Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice. , 2012, Cardiovascular research.

[21]  P. Pandolfi,et al.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.

[22]  Lanbing Yu,et al.  Comparative proteome analysis of saccular intracranial aneurysms with iTRAQ quantitative proteomics. , 2016, Journal of proteomics.

[23]  David Hasan,et al.  Review of Cerebral Aneurysm Formation, Growth, and Rupture , 2013, Stroke.

[24]  J. Mactaggart,et al.  Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation. , 2007, Surgery.

[25]  J. Catravas,et al.  cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue , 1996, Journal of cellular physiology.

[26]  Zhiming Wang,et al.  A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells , 2013, Experimental and therapeutic medicine.

[27]  Y. Li,et al.  A new microRNA signal pathway regulated by long noncoding RNA TGFB2-OT1 in autophagy and inflammation of vascular endothelial cells , 2015, Autophagy.

[28]  Koji Hosaka,et al.  Inflammation and Cerebral Aneurysms , 2013, Translational Stroke Research.

[29]  Jian Zhang,et al.  Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy , 2016, Oncotarget.

[30]  R. Ostrom,et al.  Human Bronchial Smooth Muscle Cells Express Adenylyl Cyclase Isoforms 2, 4, and 6 in Distinct Membrane Microdomains , 2011, Journal of Pharmacology and Experimental Therapeutics.

[31]  Anjali J. Koppal,et al.  Supplementary data: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites , 2010 .

[32]  M. Günel,et al.  Expression of Structural Proteins and Angiogenic Factors in Normal Arterial and Unruptured and Ruptured Aneurysm Walls , 2005, Neurosurgery.

[33]  K. Takakura,et al.  Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. , 2001, American journal of human genetics.

[34]  M. Banerjee,et al.  Association of Versican (VCAN) gene polymorphisms rs251124 and rs2287926 (G428D), with intracranial aneurysm , 2014, Meta gene.

[35]  K. Nozaki,et al.  Impact of Monocyte Chemoattractant Protein-1 Deficiency on Cerebral Aneurysm Formation , 2009, Stroke.

[36]  F. Sánchez‐Madrid,et al.  Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway. , 2004, Atherosclerosis.

[37]  T. Sano,et al.  Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls , 2000, Acta Neuropathologica.

[38]  N. Jafari,et al.  Genomics of Human Intracranial Aneurysm Wall , 2009, Stroke.